USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS OF THE PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PSUMMIT I STUDY

被引：0

作者：

McInnes, I. B. ^{[1
]}

Kavanaugh, A. ^{[2
]}

Gottlieb, A. B. ^{[3
]}

Puig, L. ^{[4
]}

Rahman, P. ^{[5
]}

Ritchlin, C. ^{[6
]}

Li, S. ^{[7
]}

Wang, Y. ^{[7
]}

Mendelsohn, A. M. ^{[7
]}

Doyle, M. K. ^{[7
,8
]}

机构：

[1] U Glasgow, Glasgow, Lanark, Scotland

[2] U Calif, San Diego, CA USA

[3] Tufts Med Cntr, Boston, MA USA

[4] Univ Autonoma Barcelona, E-08193 Barcelona, Spain

[5] Mem U, St John, NF, Canada

[6] U Rochester, Rochester, NY USA

[7] Janssen R&D, Spring House, PA USA

[8] U Penn, Philadelphia, PA USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷

关键词：

D O I：

10.1136/annrheumdis-2012-eular.1841

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：107 / 107

页数：1

共 50 条

[21] Secukinumab improves active psoriatic arthritis and inhibits radiographic progression: Results of a phase 3 randomized, multicenter, double-blind, placebo-controlled study
Mease, P.
McInnes, I. B.
Kirkham, B.
Kavanaugh, A.
Rahman, P.
Van Der Heijde, D.
Landewe, R.
Nash, P.
Pricop, L.
Yuan, J.
Richards, H.
Mpofu, S.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S29 - S29
[22] Continued Improvement of Signs and Symptoms in Patients with Active Psoriatic Arthritis: Week 52 Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study.
Kavanaugh, Arthur
McInnes, Iain B.
Gottlieb, Alice B.
Puig, Lluis
Rahman, Proton
Ritchlin, Christopher T.
Li, Shu
Wang, Yuhua
Doyle, Mittie K.
Mendelsohn, Alan M.
ARTHRITIS AND RHEUMATISM, 2012, 64 (12): : 4168 - 4168
[23] Safety of efalizumab in patients with psoriatic arthritis: Results of a phase II, randomized, double-blind, placebo-controlled study
Papp, K
Mease, P
Garovoy, M
Zhang, D
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P156 - P156
[24] Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study
Leng, Xiaomei
Lin, Wei
Liu, Shixue
Kanik, Keith
Wang, Cunshan
Wan, Weiguo
Jiang, Zhenyu
Liu, Yi
Liu, Shengyun
Zhang, Zhuoli
Zhang, Zhiyi
Xu, Jian
Tan, Wenfeng
Hu, Jiankang
Li, Jingyang
Liu, Ju
Gunay, Levent M.
Dina, Oluwaseyi
Kinch, Cassandra
Zeng, Xiaofeng
RMD OPEN, 2023, 9 (01):
[25] A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF AURANOFIN IN PATIENTS WITH PSORIATIC-ARTHRITIS
CARETTE, S
CALIN, A
MCCAFFERTY, JP
WALLIN, BA
ARTHRITIS AND RHEUMATISM, 1989, 32 (02): : 158 - 165
[26] Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
Deodhar, Atul
Gottlieb, Alice B.
Boehncke, Wolf-Henning
Dong, Bin
Wang, Yuhua
Zhuang, Yanli
Barchuk, William
Xu, Xie L.
Hsia, Elizabeth C.
LANCET, 2018, 391 (10136): : 2213 - 2224
[27] SULFASALAZINE IN PSORIATIC-ARTHRITIS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
FARR, M
KITAS, GD
WATERHOUSE, L
JUBB, R
FELIXDAVIES, D
BACON, PA
BRITISH JOURNAL OF RHEUMATOLOGY, 1990, 29 (01): : 46 - 49
[28] Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis - Results of a double-blind, randomized, placebo-controlled trial
Mease, PJ
Gladman, DD
Ritchlin, CT
Ruderman, EM
Steinfeld, SD
Choy, EHS
Sharp, JT
Ory, PA
Perdok, RJ
Weinberg, MA
ARTHRITIS AND RHEUMATISM, 2005, 52 (10): : 3279 - 3289
[29] EFFICACY AND SAFETY OF USTEKINUMAB IN PSA PATIENTS WITH SPONDYLITIS AND PERIPHERAL JOINT INVOLVEMENT: RESULTS FROM A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Kavanaugh, A.
Puig, L.
Gottlieb, A. B.
Ritchlin, C.
You, Y.
Wang, Y.
Mendel-sohn, A. M.
Song, M.
Rahman, P.
McInnes, I. B.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 825 - 825
[30] Alefacept in combination with methotrexate for the treatment of psoriatic arthritis - Results of a randomized, double-blind, placebo-controlled study
Mease, Philip J.
Gladman, Dafna D.
Keystone, Edward C.
ARTHRITIS AND RHEUMATISM, 2006, 54 (05): : 1638 - 1645

← 1 2 3 4 5 →